Literature DB >> 12812981

Dentatorubral-pallidoluysian atrophy protein is phosphorylated by c-Jun NH2-terminal kinase.

Yuko Okamura-Oho1, Toshiyuki Miyashita, Kazuaki Nagao, Seigo Shima, Yukie Ogata, Toshiaki Katada, Hiroshi Nishina, Masao Yamada.   

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is a dominant-inherited neurodegenerative disease characterized by selective cell loss in particular neuronal pathways. This is caused by expansion of CAG repeats in the coding region of the DRPLA gene, and the extended polyglutamine tract (polyQ) confers a toxic activity. It is valuable to characterize disease gene products for elucidation of the mechanism underlying neuron death at specific anatomical areas of the brain. Here, we define the DRPLA protein as a phosphoprotein, and c-Jun NH(2)-terminal kinase (JNK) is one of the major factors involved in its phosphorylation. Endogenous DRPLA protein was serine-phosphorylated. Phosphorylation was demonstrated in a recombinant JNK activation system in vitro and also in overexpressing cells by transfection after the JNK activation with osmotic pressure. One of the phospho-acceptor sites for JNK appearing in the DRPLA sequence was indeed phosphorylated, which was confirmed by a specific antibody raised against the phosphopeptide. Kinetic studies in the JNK recombinant system showed that expanded polyQ slightly reduced the affinity of JNK to the protein. Thus, the abnormal DRPLA protein seems to be slowly phosphorylated in a certain condition of JNK activation in patients. It may delay a process that is essential in keeping neurons alive.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812981     DOI: 10.1093/hmg/ddg168

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  4 in total

1.  Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing: the case of Gln in DRPLA affects subcellular localization of the products.

Authors:  Keiko Tadokoro; Mayu Yamazaki-Inoue; Maki Tachibana; Mina Fujishiro; Kazuaki Nagao; Masashi Toyoda; Miwako Ozaki; Masami Ono; Nobuhiro Miki; Toshiyuki Miyashita; Masao Yamada
Journal:  J Hum Genet       Date:  2005-08-10       Impact factor: 3.172

2.  De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome.

Authors:  Elizabeth E Palmer; Seungbeom Hong; Fatema Al Zahrani; Mais O Hashem; Fajr A Aleisa; Heba M Jalal Ahmed; Tejaswi Kandula; Rebecca Macintosh; Andre E Minoche; Clare Puttick; Velimir Gayevskiy; Alexander P Drew; Mark J Cowley; Marcel Dinger; Jill A Rosenfeld; Rui Xiao; Megan T Cho; Suliat F Yakubu; Lindsay B Henderson; Maria J Guillen Sacoto; Amber Begtrup; Muddathir Hamad; Marwan Shinawi; Marisa V Andrews; Marilyn C Jones; Kristin Lindstrom; Ruth E Bristol; Saima Kayani; Molly Snyder; María Mercedes Villanueva; Angeles Schteinschnaider; Laurence Faivre; Christel Thauvin; Antonio Vitobello; Tony Roscioli; Edwin P Kirk; Ann Bye; Jasmeen Merzaban; Łukasz Jaremko; Mariusz Jaremko; Rani K Sachdev; Fowzan S Alkuraya; Stefan T Arold
Journal:  Am J Hum Genet       Date:  2019-02-28       Impact factor: 11.025

Review 3.  Atrophin proteins: an overview of a new class of nuclear receptor corepressors.

Authors:  Lei Wang; Chih-Cheng Tsai
Journal:  Nucl Recept Signal       Date:  2008-10-31

Review 4.  Roles of Post-translational Modifications in Spinocerebellar Ataxias.

Authors:  Linlin Wan; Keqin Xu; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.